BLUE JET HEALTHCARE
|
BLUE JET HEALTHCARE Last 5 Year Financial Ratios History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 14.29 | 17.59 | 9.44 | 9.23 | 10.47 |
| CEPS(Rs) | 15.67 | 18.62 | 11.06 | 10.67 | 11.75 |
| DPS(Rs) | 1.20 | 1.20 | 1.00 | - | - |
| Book NAV/Share(Rs) | 78.40 | 65.32 | 48.73 | 39.29 | 30.07 |
| Tax Rate(%) | 25.47 | 24.85 | 25.60 | 26.12 | 25.34 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 31.05 | 36.67 | 32.21 | 30.39 | 36.47 |
| EBIT Margin(%) | 35.76 | 39.44 | 30.95 | 30.23 | 36.07 |
| Pre Tax Margin(%) | 35.10 | 39.43 | 30.93 | 30.04 | 35.59 |
| PAT Margin (%) | 26.16 | 29.63 | 23.01 | 22.20 | 26.57 |
| Cash Profit Margin (%) | 28.69 | 31.36 | 26.96 | 25.67 | 29.81 |
| Performance Ratios | |||||
| ROA(%) | 13.58 | 21.22 | 14.75 | 17.74 | 26.11 |
| ROE(%) | 19.88 | 30.85 | 21.45 | 26.60 | 42.16 |
| ROCE(%) | 27.18 | 41.06 | 28.85 | 36.24 | 54.01 |
| Asset Turnover(x) | 0.52 | 0.72 | 0.64 | 0.80 | 0.98 |
| Sales/Fixed Asset(x) | 2.16 | 2.96 | 2.81 | 3.24 | 3.50 |
| Working Capital/Sales(x) | 1.30 | 1.37 | 1.42 | 1.47 | 1.83 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.46 | 0.34 | 0.36 | 0.31 | 0.29 |
| Receivable days | 132.65 | 93.28 | 106.77 | 118.17 | 99.18 |
| Inventory Days | 86.94 | 69.77 | 65.53 | 58.39 | 59.48 |
| Payable days | 61.13 | 47.23 | 48.81 | 59.93 | 73.70 |
| Valuation Parameters | |||||
| PER(x) | 22.91 | 50.06 | 40.51 | - | - |
| PCE(x) | 20.88 | 47.30 | 34.58 | - | - |
| Price/Book(x) | 4.17 | 13.48 | 7.85 | - | - |
| Yield(%) | 0.37 | 0.14 | 0.26 | - | - |
| EV/Net Sales(x) | 5.84 | 14.72 | 9.20 | -0.04 | -0.08 |
| EV/Core EBITDA(x) | 15.24 | 35.75 | 25.38 | -0.13 | -0.20 |
| EV/EBIT(x) | 16.32 | 37.32 | 29.74 | -0.14 | -0.21 |
| EV/CE(x) | 4.06 | 13.38 | 7.75 | -0.05 | -0.10 |
| M Cap / Sales | 5.99 | 14.83 | 9.32 | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | -8.03 | 44.74 | -1.30 | 5.49 | 36.99 |
| Core EBITDA Growth(%) | -14.44 | 64.28 | 6.19 | -9.54 | 24.70 |
| EBIT Growth(%) | -16.60 | 84.42 | 1.05 | -11.58 | 25.91 |
| PAT Growth(%) | -18.80 | 86.38 | 2.33 | -11.88 | 28.23 |
| EPS Growth(%) | -18.80 | 86.38 | 2.33 | -11.88 | -99.27 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 3.64 | 2.50 | 2.38 | 2.54 | 2.44 |
| Quick Ratio(x) | 2.96 | 1.97 | 2.02 | 2.15 | 2.04 |
| Interest Cover(x) | 54.30 | 4,144.87 | 1,368.05 | 160.39 | 74.71 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of BLUE JET HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLUE JET HEALTHCARE | ₹10,897.1 Cr | -0.6% | -2.6% | -18% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,316.0 Cr | -1.9% | -3.7% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,737.0 Cr | 2.6% | 11.1% | 56% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,594.0 Cr | 0.2% | 1.3% | 38% | Stock Analytics | |
| CIPLA | ₹110,515.0 Cr | -1.5% | -6.4% | -12.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.6 Cr | -1% | -5.1% | -8.1% | Stock Analytics | |
BLUE JET HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLUE JET HEALTHCARE | -0.6% |
-2.6% |
-18% |
| SENSEX | -2.4% |
-4.8% |
-7.2% |
You may also like the below Video Courses
